5a, b ); immunofluorescence analysis of tumor tissues showed a trend toward increased B-cell infiltration after STING agonist-treatment versus control (Supplementary Fig. 5c, d ).
← all excerpts
Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma.
1
—
—